CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,700 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005676
NCT00005676N/ACompleted
CompareCT.gov

High Density Lipoprotein Subspecies and Coronary Disease

Tufts University·observational·Posted May 26, 2000·Updated Mar 4, 2014

In Brief

An observational study for Cardiovascular Diseases and 3 related conditions. Completed, enrolled 2,700 participants.

Detailed Summary

To investigate the relative contributions of high density lipoprotein-C (HDL-C) subspecies to risk for coronary heart disease (CHD) in two distinct existing populations (samples from the VA-HIT study and the Framingham Offspring Study \[FOS\]) as well as the response of these subfractions to gemfibrozil treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Coronary Disease, Coronary Arteriosclerosis, Heart Diseases
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartApr 1, 2000
Primary CompletionAug 1, 2005
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 26.1 years ago